Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by G. Oguzhan Ergın
Pcv70 - Effect of Time in Therapeutic Range on Cost and Clinical Outcomes of Atrial Fibrilation Patients : A Cost-Consequences Analysis of Rivaroxaban vs Warfarin for Turkey
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Pcv65 - Expert Analysis on Cost Analysis of Management of Cardiovascular Disease Co-Morbidities
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Related publications
Renal Function, Time in Therapeutic Range and Outcomes in Warfarin-Treated Atrial Fibrillation Patients: A Retrospective Analysis of Nationwide Registries
Thrombosis and Haemostasis
Hematology
Evaluating Time in Therapeutic Range for Hemodialysis Patients Taking Warfarin
Clinical Nephrology
Medicine
Nephrology
Pcv51 - Cost Analysis of Safety Outcomes of Dabigatran vs. Warfarin in the Spanish National Health Service
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Comparative Pharmacoeconomic Analysis of Rivaroxaban and Warfarin Usage in Patients With Non-Valvular Atrial Fibrillation
Jounal of arrhythmology
Cost-Effectiveness Analysis of Apixaban Against Warfarin for Stroke Prevention in Patients With Nonvalvular Atrial Fibrillation in Japan
Clinical Therapeutics
Pharmacology
The Cost-Effectiveness of Apixaban Compared to Warfarin, Aspirin, Rivaroxaban and Dabigatran in Ireland
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Rivaroxaban Versus Warfarin in Nonvalvular Atrial Fibrillation
Yearbook of Cardiology
Cost-Effectiveness of Rivaroxaban for the Prevention of Stroke in Patients With Non-Valvular Atrial Fibrillation – A Multinational Study
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Dabigatran Compared With Rivaroxaban vs Warfarin
JAMA Internal Medicine
Internal Medicine
